ecancer
ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.
SWOG S1320 Updates on BRAFV600E-Mutated Melanoma: Can Intermittent vs. Continuous Dosing of Dabrafenib & Trametinib Overcome the Problem of Drug Resistance? Is There an Improvement in PFS?
By
ecancer
FEATURING
Alain Algazi
By
ecancer
FEATURING
Alain Algazi
Login to view comments.
Click here to Login